Placebo News and Research

RSS

Expert says flu vaccination programs a pointless waste of money

According to a vaccine expert the millions spent on flu vaccination programs each year are a waste of time and money.

30 Oct 2006

Shingles vaccine for seniors gets the green light

A government advisory panel in the United States has given it's backing for a new vaccine against shingles.

26 Oct 2006

Combination therapy of salmeterol and fluticasone improves survival in patients with COPD

A combination of two common medications may help patients with chronic obstructive pulmonary disease (COPD) live longer.

23 Oct 2006

FDA approves Omnaris, new hay fever drug

The U.S. Food and Drug Administration (FDA) has announced the approval of Omnaris (ciclesonide) nasal spray, a new drug for the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis, commonly known as hay fever, in adults and children 12 years of age and older.

23 Oct 2006

Squalenoyl nanomedicines as potential therapeutics

Nucleoside analogs such as cytarabine and gemcitabine are powerful anticancer agents, but a simple chemical modification that causes them to assemble into stable nanoparticles could make them even more valuable in the treatment of a wide variety of cancers.

23 Oct 2006

Antibiotic gives long acting relief to irritable bowel sufferers

Researchers in the U.S. say that a long-acting antibiotic can help treat the symptoms of irritable bowel syndrome (IBS).

19 Oct 2006

Contraceptive options in the U.S. examined

The New York Times on Tuesday examined contraceptive options in the U.S., where 60% of unplanned pregnancies occur among women who use contraception.

17 Oct 2006

Drug therapy for heroin addicts helps women quit smoking

New research is suggesting that women trying to quit smoking can be helped by taking medication approved for the treatment of alcohol and heroin dependence.

10 Oct 2006

Schizophrenia drug to be used to treat autism

A drug normally used to treat schizophrenia has been given approval by the U.S. the Food and Drug Administration for use in treating the symptoms of autism in children and adolescents.

9 Oct 2006

FDA approves Risperdal to treat irritability associated with autism

The U.S. Food and Drug Administration (FDA) has approved Risperdal (risperidone) orally disintegrating tablets, an adult antipsychotic drug, for the symptomatic treatment of irritability in autistic children and adolescents.

8 Oct 2006

Feeling stressed? have a cuppa...then have another!

According to the latest research regular cups of tea can help speed recovery from stress.

5 Oct 2006

New drug a breakthrough in the treatment of AMD

Age-related macular degeneration (AMD), is a common cause of vision loss and often affects older people.

5 Oct 2006

Six shot course gives two year protection from hay fever

An experimental vaccine is promising to prevent hay fever symptoms for at least two years, and this is after just six injections.

5 Oct 2006

Taking sildenafil will worsen sleep apnea

According to Brazilian researchers, taking Viagra (sildenafil) at bedtime may aggravate breathing problems in patients with severe obstructive sleep apnea.

4 Oct 2006

Progesterone improves outcomes for victims of traumatic brain injury

A new study suggests that giving progesterone to victims with Traumatic Brain Injury (TBI) shortly following brain injury may reduce the risk of death and the degree of disability, and appears to be safe.

3 Oct 2006

Raloxifene reduces breast cancer risk in postmenopausal women

Raloxifene protects postmenopausal women from developing invasive breast cancer whether they are at high or low risk of developing the disease, according to a new study.

13 Sep 2006

Nicotine shows potential medical benefits

Nicotine may improve the symptoms of depression in people who do not smoke, Duke University Medical Center scientists have discovered.

12 Sep 2006

SSRIs associated with severe violence in a small number of individuals

Use of one class of antidepressant drugs, the SSRIs (selective serotonin reuptake inhibitors), may be associated with severe violence in a small number of individuals say the authors of paper published in PLoS Medicine.

12 Sep 2006

Rivastigmine improves memory loss for traumatic brain injury patients

Traumatic brain injury patients with moderate to severe memory loss improved their memories while taking the drug rivastigmine, according to a study published in the September 12, 2006, issue of Neurology.

12 Sep 2006

Drug infliximab may help ease ulcerative colitis

In good news for patients with stubborn cases of ulcerative colitis, a serious intestinal disorder, a new research review suggests that the drug infliximab can be a useful alternative if other treatments don't work.

12 Sep 2006